On a same-hospital basis, CHS reported a 2.1 percent decline in admissions compared to the same period of 2014. When adjusted for outpatient activity, the hospital chain reported a 0.1 percent decline.
Along with weakness in volume, CHS said a deterioration in its payer mix during the first half of the year led to lower than anticipated net operating revenues during the period.
CHS also increased the number of employed physicians, which caused its cost of salaries and benefits to increase to 46.2 percent of net revenue in the third quarter, up from 45.7 percent of net revenue in the same period of the year prior.
CHS expects to report third-quarter income from continuing operations of $121 million on $4.84 billion in revenue, compared to $133 million from continuing operations on $4.78 billion in revenue for the same period in 2014.
The hospital network’s shares fell 15 percent in after-hours trading on Wednesday to $34.41, according to The Wall Street Journal.
CHS is scheduled to report full results on Nov. 2.
More articles on healthcare finance:
San Antonio hospital shuts down
Denver-area hospitals see profit margins soar
5 healthcare CFOs in the headlines
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
